Genaissance Pharmaceuticals, Inc.

Discovery and use of human gene variation for the development of personalised medicines and DNA-based diagnostics

Genaissance was founded by Kevin Rakin and Gualberto Ruano who resigned as CSO in summer 2003.

In 2003 Genaissance Pharmaceuticals, Inc. purchased most of DNA Sciences’ assets, including the clinical genotyping facility in Morrisville, NC.

Kevin Rakin (CEO)
Ben D. Kaplan (CFO)
Richard S. Judson (CSO)

Juergen Drews (Chairman)
Karen A. Dawes
Joseph Klein
Harry H. Penner, Jr
Kevin Rakin
Seth Rudnick
Christopher Wright

Five Science Park
New Haven, CT 06511
USA
Phone: +1-203-773-1450
Fax: +1-203-562-9377

Genaissance’s HAP™ Technology allow genetic variation and population genomics to be integrated into the development of new DNA-based diagnostic and therapeutic products.